Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BMS 777607

Known as: BMS-777607, BMS777607, MET Tyrosine Kinase Inhibitor BMS-777607 
An inhibitor of MET tyrosine kinase with potential antineoplastic activity. MET tyrosine kinase inhibitor BMS-777607 binds to c-Met protein, or… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Purpose Receptor tyrosine kinase AXL (RTK-AXL) is regarded as suitable target in glioma therapy. Here we evaluate the anti… Expand
Is this relevant?
2014
2014
The Axl receptor tyrosine kinase (RTK) has been established as a strong candidate for targeted therapy of cancer. However, the… Expand
Is this relevant?
2014
2014
Targeted inhibition of MET/RON signaling by tyrosine kinase inhibitor BMS-777607 for cancer treatment is currently under clinical… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
The RON receptor tyrosine kinase is a therapeutic target for cancer treatment. Here, we report therapeutic effect and phenotypic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
BACKGROUND We evaluated the mutation status of c-Met in small cell lung cancer (SCLC) and neuroendocrine tumors (NET), for which… Expand
Is this relevant?
2013
2013
Tyrosine kinase inhibitor BMS-777067 is an inhibitor of RON/MET receptor tyrosine kinases currently under clinical trials. Here… Expand
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Measuring the states of cell signaling pathways in tumor samples promises to advance the understanding of oncogenesis and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
Abstractc-Met tyrosine kinase hyperactivation is strongly associated with tumor metastasis. In a prior study we showed that BMS… Expand
  • figure 2
  • figure 1
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Most prostate cancer–related deaths are due to advanced disease with patients with metastatic prostate cancer having a 5-year… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Substituted N-(4-(2-aminopyridin-4-yloxy)-3-fluoro-phenyl)-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamides were… Expand
  • table 1
  • figure 3
  • figure 1
  • table 3
  • table 2
Is this relevant?